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PathogensThe living world has evolved and is evolving through interspeciﬁc relationships between organisms. The
diversity of these interactions is enormous going from mutualism to parasitism. Humans live with a mul-
titude of microorganisms, essential for their biology. However, interactions are not always advantageous.
Indeed, many organisms might become pathogens, such as the Plasmodium species, the causative agents
of malaria. Like many other microorganisms, they are «Machiavellian» in their capacity to elaborate a
range of reproduction strategies, giving them a huge advantage in terms of adaptation. Here, we discuss
the role played by parasites in the ecology and evolution of living organisms and particularly of humans.
In the study of infectious diseases, humans are legitimately the focal point, although they represent only
one ecosystem among many others and not taking this into account certainly biases our global view of
the system. Indeed, we know only a minimal fraction of the microorganisms we live with. However, par-
asites have shaped and are still shaping the human genome. Several genetic signatures are the proofs of
the selection pressures by parasites that humankind has endured during its evolution.
But, ultimately, what are the solutions for living with pathogens? Should we eradicate them or should
we learn how to control and manage them?
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ploit the environment (earth, water and air) that has been offered
to them following the modiﬁcation of the physico-chemical prop-erties of Earth. Human beings are just one of such organisms, but
they try to colonise everything as they now envisage the conquest
of other planets as well. One of the downside of this desire of col-
onisation is the exploitation of life forms by other organisms, i.e.,
what nowadays is deﬁned as symbiotism in the broadest sense.
However, these interspeciﬁc, tight relationships are not limited
to parasitism. Indeed, the term of parasite or pathogen is used only
for organisms that exploit their host, or in other words, that cause
physical, physiological and other damages to the host. The world of
such interactions is far richer as there are also associations that
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other any longer (mutualism), the most beautiful example of
which is the eukaryotic cell, i.e., the association of a genome with
a bacterium named mitochondrion. Parasitism and mutualism
coexist within our biosphere and a game theory model has been
proposed to summarise and analyse all the possible interactions
(Renaud and de Meeûs, 1991). This simple model considers that
host and parasite interact and that natural selection acts as an arbi-
ter relative to the functions of utility of the game, i.e., the gains ob-
tained by each of the two players. The game is based on two
strategies that can be adopted by the host and the parasite and
on the interactions between these strategies in terms of selective
values for the two of them. This game, named «The Killer and
The Diplomat» proposes a strategy of aggression and one of com-
promise. The question is: Parasitism: compromise or conﬂict?
The game solutions can be deﬁned in terms of Evolutionarily Stable
Strategy (ESS, i.e., a strategy which cannot be invaded by any other
strategy, thus conferring the adaptive optimum). The game solu-
tions can thus be summarised as follows:
– There are two ESS (conﬂict or compromise) that are deﬁned in
function of the associated costs. Indeed, in the absence of costs
related to resistance or virulence, there can be only one strategy
(i.e., conﬂict, which implies the maximal virulence for the par-
asite and the maximal resistance for the host). However, costs
associated with these two parameters (virulence and resis-
tance) do exist and the examples in the literature are abundant
(Burdon and Thrall, 2003; Sturm et al., 2011). For this reason,
interactions tend to move towards situations of compromise
in which the parasite minimizes its virulence and the host its
resistance. This might seem trivial, but it had to be formally
demonstrated. All the situations are thus feasible in nature in
function of how the interactions will develop. Nevertheless, it
is not possible to say, as often found in the literature, that a
host/parasite association will always develop toward lesser vir-
ulence or lesser resistance;
– The utility functions of the game (the outcomes of the confron-
tations) then show that: (a) mutualism is just a form of parasit-
ism in which the costs are positive, (b) commensalism (where
the host accommodates a commensal that does not exploitHuman Microbiome
Human Genome
HUMAN SPECIES
Fig. 1. The microbiome is the expression of the ecological conditions of the milieu
(such as temperature, pH, content in hormones, lipids and proteins, UV exposure,
absence of light, type of mucosa . . .), to which the involved microbial communities
(which are deﬁned as microbiota or ﬂora) will react, individually and/or collec-
tively, and which they can modify or maintain. It is currently thought that the
micro-organisms living on or within a human being exceed of a factor of 10 the
number of cells that constitute the human body. However, only 1% of them are
currently referenced. The bacteria of the human body represent millions of genes in
comparison to the 23,000 genes of the human genome.the host) is a point of non-equilibrium that may sway towards
mutualism or parasitism and so on, (c) parasitoids (i.e., very vir-
ulent parasites) are just organisms that have progressed
towards the ‘‘conﬂict’’ conﬁguration of the game.
Accordingly, the game solution is twofold and the evolution of a
biotic interaction can move towards cooperation (i.e., mutualism)
or aggression (i.e., parasitism). The cursor is thus variable.
The multitude of interactions that governs, at least partially, the
evolution of the species of our planet concerns all (viral, bacterial,
animal or vegetal) living organisms. The modalities of these inter-
actions are many as our world is rich in life forms and an entire
existence would not be enough to make the inventory of all of
them. Hence, we will try to describe this richness by choosing to
focus on the parasites and pathogens of the species that concerns
us most: the human species.1. Humans, their genome and the diversity of their symbionts
Humans, who are considered by many among us as the epitome
of evolution, cannot live alone, that is without the symbionts that
are associated with them. Generally, a eukaryotic organism cannot
be considered as autonomous without the contribution of a multi-
tude of organisms that are deﬁned as its microbiome. A study pub-
lished in 2007 showed that 90% of the cells in the human body are
bacteria, fungi, protozoa (i.e., non-human cells). The current esti-
mation of the human microbiome (i.e., the organisms that live on
or inside Homo sapiens) exceeds of a factor of 10 the number of so-
matic and germinal cells of an individual (Turnbaugh et al., 2007).
If we consider only the human intestine as an example, it contains
on average 40,000 species of bacteria (Frank and Pace, 2008) and
9 million of unique bacterial genes [(Yang et al., 2009) – Fig. 1].
The immensity of this gene diversity can be better appreciated
when compared to the 23,000 genes that compose the human gen-
ome. However, at most only 1% of the humanmicrobiome has been
characterised so far (Marcy et al., 2007). Therefore, we cannot any
longer consider any organism as isolated, as we are all super-
organisms the metabolic functions of which are the result of the
expression of micro-organisms and human genes (Gill et al.,
2006). One of the most illustrative examples is the gut microbiota,
the densest microbial population in the human body. Kovatcheva-
Datchary et al. (2013) describe this population as an organ itself,
composed of 1000–1200 cell types (species) that encode 150-fold
more genes (microbiome) than we have in our own genome. They
report that it plays a fundamental role in human health, as it
evolved speciﬁc functions that complement human metabolism
and physiology. As example, intestinal bacteria take part in vitamin
production, regulation of hormone synthesis, and maturation of
the immune system.
Nevertheless, the interactions between all these symbiotic
organisms are not always polite and mutually favourable; there
are scroungers that can become pathogens. As example, Taur and
Pamer (2013) explain that the modiﬁcation of the intestinal micro-
biota and especially the loss of the microbial stability in humans
can lead to the overgrowth or domination of pathogenic bacteria.
Indeed, in the case of immune suppression, antibiotics as well as
impairment of host immunity can cause the disruption of the mic-
robiota giving rise to perturbations favouring intestinal domina-
tion by pathogenic species.
All the complexity of the relationships among living organisms
resides in the type of interactions that they establish with their
neighbours. Accordingly, resistance to antibiotics, which is a major
public health issue, has been around since the dawn of time. This
resistance appeared well before the use by humans of medicinal
drugs. Indeed, a very recent study on sediments of the Canadian
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Fig. 2. The parasites that belong to the Apicomplexa group are the result of a double symbiosis. (A) Based on their morphological, biochemical and molecular (nucleus and
mitochondria) characteristics, their phylogenetic position is together with Ciliates and Stramenopila (position in mauve). If the presence of the plastid (circular DNA of 35 kb)
within their cytoplasm is taken into account, Apicomplexa should be classiﬁed between plants and algae (position in green). (B) Parsimonious hypothesis about the origin of
Apicomplexa as derived from a double symbiotic acquisition of (i) a mitochondrion like all eukaryotes and of (ii) a plastid from green algae that indicates a lateral transfer
which gave rise to the apicoplast. The ancestor of Apicomplexa was presumably a protozoan that ate algae. Modiﬁed from Roos et al. (1999).
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quences that correspond to resistance genes which certainly al-
lowed these bacteria to defend themselves against aggressors
(D’Costa et al., 2011).2. The multiple features of Plasmodium
The world of host/pathogen relationships is immense and its
diversity can sometimes be overwhelming. This is well illustrated
by the example of malaria which is the ﬁrst parasitic disease in
the world caused by unicellular eukaryotes. This disease, which
still kills about one million children per year, is caused by blood
parasites, protozoa of the genus Plasmodium. One might think that
this is a very simple organism because it is unicellular . . . . Far from
it. Let’s see why.
The Plasmodium parasites belong to the Apicomplexa group like,
for instance, the Toxoplasma species. If we analyse the phyletic po-
sition of these parasites, we see that they are very close to ciliates
in the evolutionary tree (Fig. 2A). Indeed, these organisms have
morphological, molecular, biochemical and pharmacological char-
acteristics that bring them close to ciliates and dinoﬂagellates (Le-
vine, 1988; Roos et al., 1999). Nevertheless, the discovery of a
circular DNA of 35 kb incorporated in the cytoplasm of Apicom-
plexa has been a puzzle for a long time. Molecular sequencing of
this element showed that it was much closer to the plastids found
in algae than to a cyanobacterium or any other free prokaryote
(Kohler et al., 1997). Thus, the presence of this plastid suggests that
Apicomplexa should be rather grouped with plants. The most par-
simonious hypothesis to explain this situation is the existence of a
lateral transfer of an algal plastid that occurred in the ancestor of
Apicomplexa. These organisms should thus be the result of a dou-
ble symbiosis (Fig. 2B): (1) the acquisition of mitochondria like all
eukaryotes and (2) the secondary integration of a plastid that led to
a new symbiosis at the origin of the apicoplastid. In other words,
the ancestor of the Apicomplexa should have been a eukaryotic
protozoan that fed on algae and this «algaevory» allowed the inte-
gration of the plastid in the structure of the protozoan, giving birth
to the Apicomplexa group. How did they become parasites remains
a mystery; however, it must be acknowledged that this double
symbiotic event has been a success because the group is much
diversiﬁed. Just as an example, it has been possible to catalogue
more than 180 species of the genus Plasmodium that parasite Rep-
tiles, Birds and Mammals. But there is still more to come . . . .
If humans have two separated sexes (female and male), this is
not the case for Plasmodium. They are anyhow sexuated organisms,because the same genotype produces male and female gametes.
They are hermaphrodites. Moreover, in the cycle of these parasites
there are also phases of asexual mitotic reproduction. Thus, asexu-
ality and sexuality are two assets of the biology of reproduction of
these parasites. Indeed, two studies carried out in Kenya (Razakan-
drainibe et al., 2005) and Cameroun (Annan et al., 2007) showed
that they can undergo self-fertilisation (i.e., here, union of gametes
from the same individual, with the same genotype) and out-cross-
ing (union of gametes originating from two different genotypes).
Even better, it has been demonstrated that reproduction in this
parasite is due for 1=4 to self-fertilisation and for 3=4 to out-crossing.
These organisms have thus a policy of reproductive assurance to
maintain their genotype by self-fertilisation and propose new com-
binations through out-crossing (Dornier et al., 2008). Furthermore,
another work has demonstrated that these parasites can also ad-
just their sex ratio (i.e., differential production of female and male
gametes) to optimise their chances of fertilisation, and thus their
ﬁtness (Paul et al., 2000).
These protozoa are «Machiavellian» because they present all
possible reproductive options: sexuality, asexuality, self-fertilisa-
tion, out-crossing, sex ratio adjustment . . . Such large reproductive
choice gives an enormous advantage to these parasites, and there-
fore it is easy to understand the difﬁculty humans have to face for
putting in place effective means to ﬁght them.3. Human evolution and parasitism
What roles do pathogens play in the ecology and evolution of
the living world? Terriﬁc question. The time when only parasitolo-
gists were interested in parasites is well and truly over. Nowadays,
the inﬂuence of parasitism on the evolution of living organisms is
for some scientists a major research theme and for others an option
that must obligatorily be taken into account given the fact that all
living organisms are concerned by parasitism. If in the past, work
was focused mainly on the direct effects of pathogens on the fecun-
dity and survival of their hosts, the current research is highlighting
their inﬂuence on host traits as different as behaviour, morphology
and physiology, to mention only a few. And what about the human
species?
During their evolution, humans have always lived in contact
with rich and diversiﬁed communities of pathogens. For instance,
although the habitat of the ﬁrst hominids was limited to tropical
savannahs, human migrations as well as the colonisation of more
temperate regions have been accompanied by the exposure to
new parasites (Armelagos et al., 1996). The structure and the size
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the dynamics and diversity of the parasite populations. Before
the Neolithic, the social groups were mostly too modest in size
to allow the maintenance of endemic diseases. An important
change during the Neolithic was the organisation of sedentary
societies around villages that grouped together many more indi-
viduals. An almost immediate consequence was the appearance
and maintenance of many infectious diseases, such as measles,
mumps, ﬂu and smallpox. Always during the Neolithic, the proxim-
ity between humans and animals was increased by animal domes-
tication, a phenomenon at the origin of a recrudescence of
zoonoses (Polgar, 1964). Many years later, during their voyages,
European explorers spread several contagious diseases (whooping
cough, measles, smallpox . . .) that decimated many autochthonous
populations (e.g., Amerindians), thousands and thousands of kilo-
meters away from their country of origin.
Therefore it is unconceivable that the species Homo sapiens,
who is nothing else than a particular animal, would not have been
inﬂuenced during its evolution by parasitic constraints. It is worth
noting that infectious disease mortality has remained virtually un-
changed from Paleolithic times since the advent of antibiotics and
vaccines, with life expectancy of only 25 years (Casanova and
Abel, 2005). In developed countries, it is easily forgotten that an
infection nowadays can be easily cured by a simple antibiotic pre-
scription would have been lethal only few decades ago. This appar-
ently simple concept is heavy in consequences and gives an idea of
the major role played by parasitic constraints in human history.
Moreover, the phenomenon is far from being over as even nowa-
days parasites (in a broad sense) kill directly or indirectly millions
of people each year. Like all living organisms, humans have been
and remain a species subject to natural selection and pathogens
are clearly part of these selective pressures. Consciously or not, hu-
mans have developed, like other species, multiple strategies to
avoid the risks and/or the consequences of infections for them-
selves or their descendants. A review of the many articles pub-
lished during the last 15 years in human evolutionary ecology
leads to the conclusion that many aspects of human biology, par-
ticularly human life-history patterns, many behaviours and possi-
bly also the cultural and religious diversity of human populations
cannot be fully understood without taking into account the para-
sitic constraints (Thomas et al., 2012). We will now discuss a few
examples of these parasitic inﬂuences.
Guégan et al. (2001) have, for instance, shown that fertility vari-
ations in human populations are at least in part indirectly imput-
able to the diversity of the pathogen communities. Fertility
increases when the diversity of severe infectious diseases (such
as malaria, yellow fever, dengue fever, cholera . . .) also increases.
The elevated child mortality linked to diseases might thus be asso-
ciated with compensatory responses that aim at producing more
children. In addition to the description of a theoretically predict-
able adaptive response, this work also suggests that the global ﬁght
against parasitic diseases should paradoxically slow down human
demography, because, on the long term, it would cause a reduction
of fertility (by stopping the compensatory effect) in the countries
that currently are the most exposed to diseases. Birth weight could
also be inﬂuenced by parasitic pressures. Although health special-
ists often think that this variable is exclusively determined by the
current environmental constraints, several evolutionists have pro-
posed that part of the variation could be due to the inﬂuence of
natural selection. Thomas and coll. (Thomas et al., 2004) have in-
deed shown that when the number of severe infectious diseases
rises beyond a certain threshold, a concomitant increase of the
average birth weight will be also observed. As big babies are usual
more resistant to infections or tolerate better their consequences,
this result is compatible with the hypothesis that humans (like
any other mammal) maximise their selective value not onlythrough the number of their descendants, but also by giving birth
to babies with an optimal weight relative to the local environmen-
tal constraints.
When human beings do not die of old age, accidents or parasitic
diseases, they die of somatic diseases (e.g., cancers, cardiovascular
diseases, mental diseases). Although generally parasitic and so-
matic diseases are considered as opposite entities, an increasing
number of works indicate that many diseases which are thought
to be of ‘‘non-parasitic’’ origin have in reality an infectious cause
(Cochran et al., 2000). These ﬁndings are of crucial importance be-
cause infections are often preventable (by vaccination, for in-
stance) or treatable and thus the associated somatic diseases
could also be easily avoided. Cancer is particularly interesting from
this point of view. At the beginning of the 70s, about 1% of cancers
were considered to be of parasitic or viral origin. Now, the World
Health Organisation acknowledges that 20% of cancers are due to
infectious agents, particularly RNA and DNA viruses and bacteria.
For instance, hepatocellular carcinoma, stomach cancer and cervi-
cal cancer can be largely attributed to the hepatitis virus B and C,
the bacterium Helicobacter pylori and to papillomaviruses, respec-
tively. Some evolutionists, like (Ewald, 2009), think that within
2050 the great majority of cancers will be considered to have an
infectious origin. What are the characteristics of oncogenic patho-
gens and how can they transform normal cells into cancer cells?
Most of the pathogens that can cause cancers are pathogens with
sexual transmission (intercourse, heavy petting) that leads to a rel-
atively low transmission rate (in comparison to viruses, like the
one of inﬂuenza); on the other hand, the infection is persistent
and often cannot be eradicated. This feature is important for
understanding why and how these viruses can lead to the cell
deregulation which is at the origin of cancer. According to Ewald
(2009), normal cells have put in place at least four barriers to avoid
sinking into the unicellular selﬁshness of cancer cells: (i) they di-
vide only when they receive the appropriate signal; (ii) when they
accumulate too many genetic anomalies, they commit suicide (by
apoptosis); (iii) they can divide only for a limited number of times
(differently from cancer cells that have become immortal thanks to
telomerase activation); and, ﬁnally, (iv) their adhesive properties
do not allow them to detach and to migrate somewhere else, like
cancer cells do during the phase of generalization of the disease
(metastasis formation). Interestingly, although oncogenic patho-
gens are phylogenetically diversiﬁed, they all can sabotage these
four barriers to favour their survival and transmission during the
long years they must spend in their host and avoid the immune
system. The problem of this sabotage is that it allows the accumu-
lation of mutations without elimination (by apoptosis, for in-
stance) of the cells that have been thus modiﬁed. The quantity of
mutations will be more elevated when exposure to mutagens (to-
bacco, alcohol . . .) is more important. When mutations will touch
systems that regulate the four anti-cancer barriers, cells will be
no longer simply sabotaged or ‘‘manipulated’’ by a pathogen for
its own replication strategy, they will then be transformed into
cancer cells: at that point neither the host nor the pathogen will
be able to control their anarchic divisions. There are many other
proximate mechanisms through which pathogens can transform
healthy cells into cancer cells, such as the induction of chromo-
some instability and of translocations, inﬂammation . . . [see (zur
Hausen, 2009) for a review]. Indeed, the infectious origin of cancers
is one of the hottest current research topics.
In what way the knowledge, or better the acknowledgment of
the evolutionary interactions between humans and pathogens is
important at this point in time? Humans are increasingly able to
act on the parasites which threaten them, but often without wor-
rying about the consequences that might result from disequilibria
in the evolutionary dynamics that they maintain with these same
pathogens. If intuitively it seems desirable to get rid of the parasitic
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major evolutionary force without which the world would be
different.
In recent times, in some regions, the contacts with pathogens
have strongly decreased due to important social changes. For in-
stance, the generalization of sanitation, marsh draining and the
changes in farming practices and lifestyle during the 19th and
20th centuries played a major role in the disappearance of malaria
in West Europe. More generally, the changes in life hygiene and the
generalization of immunization during the 20th century, as well as
the growing use of antibiotics starting from the 50s, have led to an
unparalleled reduction of the parasitic burden. This had important
positive consequences due to the strong, deleterious effects of
most parasites. For instance, the increase in life expectancy, tradi-
tionally attributed only to the progress of medicine, results essen-
tially from the reduction of parasitic contacts, to which medicine
has deﬁnitely contributed. It remains to be understood and this
has started to be tackled, to which extent the parasite reduction
has also contributed to other changes of this century, such as the
increase of birth weight, the reduction of fertility, the increase of
QI and so on.
The reduction in the contacts with parasites had negative con-
sequences as well, because the host-parasite co-evolution gener-
ated complex interactions. For instance, intestinal parasites, such
as helminths, have developed the capacity to regulate the type 2
immunity in order to increase their survival. On the other hand,
the regulation of the immune system has also evolved in order to
reinstate a normal expression in the presence of helminths. Thus,
the abrupt destruction of all the intestinal worms favours an im-
mune dysfunction because (in the case of helminths) a regulatory
factor is suppressed, leading to an inappropriate (autoimmune) im-
mune reaction. The recent, important emergence of different aller-
gies, Crohn’s disease, type 1 diabetes, asthma and many other
disorders might also be explained in such way. The ﬁnding that
the symptoms of Crohn’s disease can disappear following the
ingestion of the eggs of a parasite of another species (that hatch
but do not develop) paves the way to many applications for the
treatment of these diseases with non-pathogen parasites. Further-
more, the selection for strong immune responses in countries with
elevated parasite pressures is associated with inﬂammatory re-
sponses that might favour the appearance of cancer later in life.
This phenomenon, made evident by the recent lifespan lengthen-
ing, suggests that, unfortunately, cancer will be a future major
health issue in developing countries. Understanding the modiﬁca-
tions of the interactions between humans, their parasites and
health in general is certainly a promising topic as shown by the
current expansion of Darwinian medicine.4. The human species: an ecosystem among others
Infectious (bacterial, viral, fungal and parasitic) diseases still
have a devastating impact on human health. Twenty percent of
mortality worldwide and 60% in Africa are due to infectious dis-
eases, thus representing more than 17 million victims each year.
Nevertheless, the causes of phenomena of recurrence, emergence
and re-emergence of these diseases are too often not well known.
This is due to mainly the complexity of the infectious systems in
which a variety of parameters related to the vectors for vector-
borne diseases, the environment, the hosts and the pathogens act
and interact. Moreover, many factors can modify the epidemiolog-
ical context and thus the dynamics and the spreading of an infec-
tious disease. These modiﬁcations can be related to changes in the
ecosystem, to the capacities of adaptation of the infectious agents,
or to the exposure of individuals to agents that up to that moment
were conﬁned to a non-anthropised ecological niche. Among thethousand human pathogens that have been identiﬁed so far, more
than half have a zoonotic origin (like, for instance, the Ebola virus,
the virus of avian ﬂu, some species of Leishmania responsible for
leishmaniases, the borrelia species, the bacteria responsible for
Lyme disease) and an important part of these pathogens are carried
by arthropod vectors (the virus of dengue fever, the plasmodia, the
different Leishmania . . .). Moreover, recent works still highlight the
existence of new reservoirs and new vectors for diseases that have
been known already for many decades, as well as the identiﬁcation
of new micro-organisms (Leroy et al., 2009; Ollomo et al., 2009;
Prugnolle et al., 2010; Zou et al., 2010; Rougeron et al., 2011b;
Schex et al., 2011; Senghor et al., 2011; Uhlemann et al., 2011; Vas-
ilakis et al., 2011; Godreuil et al., 2012; Senghor et al., unpublished
data). This suggests that many micro-organisms and many biolog-
ical (vectors, reservoirs) and/or ecological (environment) niches re-
main to be discovered. We are thus still far from knowing all the
infectious systems and particularly the extent and distribution of
micro-organisms that are pathogen or not for humans.
An element that increases our difﬁculty at grasping the real ex-
tent of the distribution and genetic diversity of micro-organisms in
the ecosystems is the focalisation of many research projects on
pathogens. Indeed, the strains used for the studies on virulence,
resistance, genomics, experimental evolution, population genetics,
and so on, are in general clinical isolates (Rougeron et al., 2009,
2011a; Marsden et al., 2010; Downing et al., 2011; Eppinger
et al., 2011; Muller et al., 2011; Snitkin et al., 2011). This approach
axed mainly on human patients and thus on the micro-organism as
an infectious agent is largely reductive because the role of a micro-
organism as a human pathogen represents very often only a mini-
mal portion of its life-history patterns. This has been termed ‘ice-
berg bias’ (Tibayrenc, 1999). This is the case, for instance, of
Mycobacterium bovis or of the virus of mad cow disease (de la
Rua-Domenech, 2006; Hlavsa et al., 2008; Imran and Mahmood,
2011a,b). Indeed, in many infectious systems, the human species
is only an accidental host and very often an epidemiological im-
passe due to the medical treatments or because it is not a reservoir,
or due to its rapid death. This is true forMycobacterium marinum, a
ﬁsh bacterium, Ebola virus or even Leishmania infantum, responsi-
ble for canine leishmaniasis. The human compartment can thus be
seen as negligible for the majority of micro-organisms. Moreover,
some viruses or parasites have been considered for a long time
as conﬁned only to humans, but have all the potential ecological
niches that allowed them to survive in the system before emerging
in humans been thoroughly elucidated? For instance, Plasmodium
falciparum has recently been identiﬁed in gorillas (Prugnolle
et al., 2010) and Ebola virus in bats (Leroy et al., 2009).
A micro-organism is identiﬁed as a pathogen when the host im-
mune system cannot manage to control the infection and it causes
physiological malfunctions and clinical symptoms. The immune re-
sponse is heterogeneous in humans and can vary in function of the
genotype of the infecting organism and/or of the physiological sta-
tus of the host (Beck and Levander, 2000; Maciel et al., 2008;
Ajzenberg et al., 2009). Moreover, epidemiological studies show
that people are much more sensitive to infections when the af-
fected population is naive of all contacts with the emerging organ-
ism (Alcais et al., 1997; Camargo et al., 1999; Bucheton et al.,
2002). These elements show how the classiﬁcation as pathogen
for any given species of micro-organisms depends not only on
the physiological status of the infected individual, but also on the
immune status of the studied population.
As a general rule, most microbes exist and circulate as non-
pathogens independently of the environment and both in verte-
brate and invertebrate hosts. They can multiply and spread with-
out systematically causing damage to the host that accommodate
them. This is true also for humans. Indeed, although it is not very
much studied due to the absence of medical interest, the
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tion. From birth, humans live with a multitude of harmless or even
beneﬁcial micro-organisms. However, it is well known that these
micro-organisms, these human symbionts, can become pathogens
in people with a poor immune system, such as for instance individ-
uals with AIDS. Conversely, many infectious agents that have been
identiﬁed as human pathogens can circulate in humans without
producing apparent clinical symptoms. Indeed, it has been clearly
demonstrated that asymptomatic carriers (i.e., infected individuals
without apparent clinical symptoms) represent the great majority
of the human population for numerous infectious diseases. This
assumption is true for many parasitic diseases (Chagas disease,
leishmaniases, toxoplasmosis or malaria), but also for viral dis-
eases (herpes or hepatitis) as well as for bacterial diseases (tuber-
culosis and staphylococcosis). This compartment is all the more
important as it can play a role in the transmission of infectious dis-
eases. This is the case of Staphylococcus aureus that circulates
asymptomatically in more than 30% of the human population or
for Toxoplasma gondii. For leishmaniases, this compartment has
been known for about 10 years and the prevalence of asymptom-
atic carriers is higher than 30% in some studies (see for review
Bañuls et al., 2011). These works clearly show that the number of
asymptomatic carriers of the parasite Leishmania is without any
doubt higher than the number of cases of symptomatic leishman-
iasis. Similarly, for Mycobacterium tuberculosis, the agent of pul-
monary tuberculosis, the majority of infections are asymptomatic
(estimated at 1/3 of the world population) and remain latent and
only some people will develop active tuberculosis following infec-
tion (Brodie and Schluger, 2005). This compartment represents
thus an unlimited reservoir of pathogens and a major obstacle to
the eradication of tuberculosis (see review Godreuil et al., 2007).
Moreover, it should be noted that this bacterial population,
although considered as dormant, seems to evolve and keeps
acquiring mutations during the latency phase (Ford et al., 2011).
The human-centred approaches, which are mainly focused on
micro-organisms as human pathogens, are at the origin of impor-
tant biases in all research ﬁelds (population genetics, epidemiology
and biology) concerning the interpretation of data and the under-
standing of the infectious systems. The direct consequence of this
reductive approach is that we do not have access to all the biodi-
versity of the micro-organism under study. Yet, this biodiversity
is crucial for identifying and understanding the processes of trans-
mission, adaptation, evolution and co-evolution and also of
virulence.
For population genetic studies, the knowledge of the global ge-
netic diversity is a pre-requisite to determine the reproduction
strategies and the population structure. For many micro-organ-
isms, it is impossible or difﬁcult to study experimentally the mode
of reproduction, and only theoretical analyses based on the study
of the genotype distributions and allele frequencies allow predict-
ing the systems of reproduction and the evolution of populations.
In this context, to validate predictions, the sample must be repre-
sentative of the allelic diversity of the studied population. There-
fore, sampling should be as exhaustive as possible by integrating
all the compartments of the system (vectors, hosts reservoirs, envi-
ronment, symptomatic and asymptomatic carriers). This is even
more crucial because the systems of reproduction in micro-organ-
isms can be complex and manifest speciﬁc features in function of
the hosts they invade during the cycle. For instance, T. gondii, the
agent of toxoplasmosis, uses a sexual reproduction system only
in cats (deﬁnitive host) and an asexual system in all the other hosts
(humans, sheep, birds, mice . . .). Similarly, P. falciparum moves
from sexual recombination in its vector to asexual reproduction
in its vertebrate host. This clearly shows that human-centred stud-
ies and sampling bias can generate important errors of interpreta-
tion concerning the biology of these micro-organisms. A typicalexample is represented by the Leishmania model (the agent
responsible for leishmaniasis), in which past analyses generated
debatable and incomplete hypotheses concerning the system of
reproduction (for more details, see Rougeron et al., 2009, 2010,
2011a; Tibayrenc and Ayala, 2012). To study the population struc-
ture, non-representative samples of such populations and sub-pop-
ulations are also an obstacle to robust analyses. Indeed, living
organisms are generally organised in sub-populations and they
are not distributed homogeneously in the environment. It is thus
essential to take into consideration this sub-population structure
because it inﬂuences the distribution of the genetic information
and allows to avoid Wahlund effect (reduction of heterozygosity
relative to the Hardy-Weinberg equilibrium due to subdivision of
the population in several sub-populations that do not exchange ga-
metes, or very little) and thus a misinterpretation of data (De
Meeûs et al., 2006; Prugnolle and De Meeûs, 2008, 2010; Rougeron
et al., 2009, 2010, 2011c).
The other research ﬁelds that are sensitive to the choice of
microbial populations as study samples are the studies on the
host-parasite (this term is used here in a broad sense) interactions,
the biological mechanisms of virulence, resistance and pathogenic-
ity, as well as on the associated genetic determinisms. As said be-
fore, in order to try to understand the polymorphisms that are
associated with virulence and the clinical and resistance patterns
that are common to most pathogens, these research works are gen-
erally focused on clinical strains. The difﬁculty in these studies is to
distinguish between pathogen- and host-speciﬁc mechanisms. In-
deed, the physiological state of the hosts and particularly of their
immune system has an impact on symptom progression and on
the clinical outcome of patients (Beck and Levander, 2000; Maciel
et al., 2008). Therefore, it is difﬁcult to target the genes and the reg-
ulatory mechanisms that are put in place by the micro-organisms
to infect their hosts and, consequently, also to explain their patho-
genic features. A line of research that has not yet been exploited
enough in the ﬁeld of infectious diseases is the comparison be-
tween pathogenic and non-pathogenic forms of a micro-organism,
although it has been done for S. aureus for a long time. The compar-
ison of the community and clinical strains or non infecting/infect-
ing strains has brought important information on the mechanisms
of virulence in these bacteria (Feng et al., 2008; Sotto et al., 2008;
Otto, 2013). This type of study could also bring precious informa-
tion for understanding the pathogenic potential of many other mi-
cro-organisms. For the model Leishmania, each clinical form of the
disease is statistically associated with a speciﬁc Leishmania species
(Bañuls et al., 2007; Bañuls et al., 2011). However, there is also an
intra-speciﬁc clinical polymorphism and the role played by the
parasite in it is not really known. So far, in both in vivo and
in vitromodels, only the strains from patients with more or less se-
vere clinical forms have been studied (see review Bañuls et al.,
2007). In these works, some rare associations were identiﬁed, but
they could not be validated as general rules (see review Bañuls
et al., 2007). The genomic, phenotypic and experimental (in vivo
and in vitromodels) comparison of strains of the same species from
asymptomatic carriers and from symptomatic patients could bring
fundamental information on the pathogenic polymorphisms of
these parasites and on the involved biological and genetic mecha-
nisms. This is particularly relevant as the ﬁrst comparative molec-
ular studies show a genetic differentiation between pathogenic and
non-pathogenic forms of parasites (Bañuls et al., 2011, Hide et al.,
2013), suggesting an intra-speciﬁc genetic determinism of the
pathogenic capacity in Leishmania.
The resistance to anti-microbial compounds is also a ﬁeld of re-
search in which the human-centred approach can bias the inter-
pretations and the decision-making in terms of control of
infections. Indeed, the phenomena of resistance are generated by
the drug selective pressure that is applied on the populations of
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medicine, but also in veterinary medicine with a comparable con-
sumption of antibiotics in animals and humans. Some studies
clearly show that the veterinary use of antibiotics leads to the
emergence of resistance to anti-microbial drugs in humans as well
(Smith et al., 2005; Shryock and Richwine, 2010). The ﬁrst risk in
human medicine is the transfer of resistant bacteria from animals
to humans. It has been reported that the frequency of intestinal
carriage of enterobacteria that are resistant to antibiotics used in
veterinary medicine is signiﬁcantly more important in farmers
than in the urban population (Piddock, 1996; van den Bogaard
et al., 1997; Kuhn et al., 2005; Smith et al., 2005). The second risk
is the horizontal transfer of resistance genes from the bacteria
hosted by the animal to pathogenic bacteria or human commen-
sals. Indeed, the digestive tract of animals and humans is an eco-
system colonised by a microbial ﬂora in which exchanges can
occur as well as the dissemination of resistance genes within the
bacterial populations that colonise it (Werner et al., 2000; Smith
et al., 2005). These examples of resistance transfer between the
animal world and humans show yet again the risk of limiting the
studies to human pathogens and the necessity of trying to under-
stand the populations of micro-organisms in their totality by inte-
grating all the ecosystems in which they develop and interact.
All these elements emphasise that still nowadays we have ac-
cess only to a minimal part of the population of micro-organisms
we live and evolve with. Yet they have a considerable impact on
the human populations in terms of demography and public health
not only as symbionts, but also and particularly as pathogens. In-
deed, infectious diseases have accompanied the human species
all along its history and have contributed to shaping its evolution.5. Parasites have shaped and still are shaping the human
genome
During their evolution, all organisms have been and are chal-
lenged by parasites. Humans have not escaped this rule either,
and if they managed to eliminate predators and competitors, this
was not case for pathogens. Hence, the human genetic history is
shaped by events that trace back the relations between humans
and the pathogens that attacked and still attack them. We are
not going to review here all the human genes that are marked by
the contact with parasites (Barreiro and Quintana-Murci, 2010),
we will consider just the case of malaria. Drepanocytosis or
sickle-cell anaemia is a genetic disease that causes a heavy public
health burden, particularly in West Africa. This red blood cell dis-
ease was identiﬁed a century ago. It is caused by a point mutation
that modiﬁes the structure of the beta chain of haemoglobin by a
simple substitution of an amino acid in position 6 (Herrick,
1910). Very quickly, scientists became aware of the existence of
a paradox, because this disease, which is very severe in homozy-
gotes who carry the mutant allele, had an abnormally high fre-
quency in Central Africa. Indeed, this disease is a genetic burden
that should have never been maintained in a context of Darwinian
selection. How to explain this? The proposed hypothesis is that
heterozygotes who carry one normal and one mutant allele are
more resistant to the parasitic attack by the malaria agents (i.e.,
P. falciparum) than homozygotes who carry two non-mutated al-
leles (Haldane, 1949). This has been deﬁned as «The malaria
hypothesis». An article published in 2010 by Piel et al. (2010)
brings the formal demonstration of the selection of this genetic
disease because of the resistance it confers to the parasitic attack
by P. falciparum.
Although we can read in some newspaper articles that humans
are not subjected to biotic selective pressures any longer, here wehave the proof of the maintenance of a genetic burden (i.e. drepan-
ocytosis) because of an infectious disease (i.e., malaria).
Moreover, this genetic system of mutant haemoglobin is not the
only one to confer an advantage in the combat against malaria. In-
deed, another major classical example in this ﬁeld concerns the
Duffy gene (FyFy) (Cutbush et al., 1950). Speciﬁcally, the absence
of antigenic determinants of the Duffy blood group system might
procure a protection against Plasmodium vivax to the majority of
individuals in Intertropical Africa (Miller et al., 1976). Neverthe-
less, it has been suggested that P. vivax could use other pathways
to enter red blood cells and that Duffy negativity might no longer
be a barrier to infection and transmission (Ménard et al., 2010;
Mendes et al., 2011).
There are many other genetic mechanisms of resistance to ma-
laria in humans, such as Glucose-6-phosphate dehydrogenase, Gly-
cophorines, Globins and Hepatoglobins, to mention only the
processes involved in the resistance. The reader may refer to the
excellent review (Kwiatkowski, 2005) to know the details of the
different processes that have been selected during the co-evolution
of humans and the agents responsible for malaria.
Pathogens have always been and still are a source of diseases
and mortality for humans; thus they impose strong selective pres-
sures that are reﬂected in the many genetic signatures which are
engraved in our genome. The knowledge of these genetic funda-
ments represents a source of essential information for progressing
in the ﬁelds of public health, clinical research and epidemiology.
On the topic of the shaping of the genome by the selective forces
of pathogens, the exhaustive work on immunology carried out by
Barreiro and Quintana-Murci is remarkable (Barreiro and Quin-
tana-Murci, 2010).
Very recently, a study has analysed and compared the environ-
mental and pathogenic factors that are responsible for the selective
pressures on the human genome (Fumagalli et al., 2011). The re-
sults show clearly that parasitic attacks are the major culprits of
the molecular signatures of the human genome in the different
populations. Brieﬂy, the authors show that 103 genes are signiﬁ-
cantly correlated in frequency with parasitic attacks, whereas no
gene could be correlated with climatic factors or the ecosystem-re-
lated life conditions. Just as an example that concerns a group of
pathogens discussed in the ﬁrst part of this review, the study re-
veals that 13 genes have been selected in our genome to ﬁght
against Leishmania infections.
Therefore, as demonstrated in this review human populations
have co-evolved with a wide range of organisms, pathogenic or
not. This co-evolution has clearly an effect on the human immun-
obiology, since our microbial partners participate in our immune
system development and in predisposition/protection from im-
mune-related diseases. In this context, the ‘‘hygiene hypothesis’’
has been proposed by Strachan in the 1980s (Strachan, 1989). This
hypothesis states that the improvement of life conditions in indus-
trialized countries, leading in a relative sterilization of the world,
have resulted in the alteration of the symbiont community in hu-
mans and thus would favour the development of chronic inﬂam-
matory disorders (for review, see Sironi and Clerici, 2010).
From the dawn of Humanity, humans have been living with par-
asites that keep attacking them without respite; this process is not
over, far from that, because humans in their demographic expan-
sion will be more and more confronted with their «enemies»; the
battle has started a long time ago and the war is far from being
won.6. Conclusion: living with pathogens in the 21st century
The world population – 7 billion currently – will reach 9–10 bil-
lion, or even more, at the end of this century. A major challenge for
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these populations, and another one will be to assure their cohabi-
tation with pathogens that have been always there, from the dawn
of life on Earth, and that belong, like us, to the big book of living
things. Chikungunya, dengue fever, AIDS, tuberculosis, malaria
are there to remind us of this. However, already during the Palae-
ozoic era, more than 300 million years ago and long before the
emergence of the human species, insects were parasitized by
viruses (Theze et al., 2011). The danger does not come from preda-
tors against which humans can defend themselves and eliminate
them, but from parasites/pathogens to which the human species
is just one ecosystem among many others, and with which humans
have to live in an intimate interaction that can be sometimes paci-
ﬁc, sometimes aggressive or even mortal for them. Now, all the
mass productions that humans will develop in the future to feed
themselves will offer to these pathogens new opportunities for
propagation.
The symbiotic interactions between pathogens and their hosts
present many facets that range from aggression (parasites/patho-
gens), when one of the two partners takes advantage of the other,
to cooperation or mutualism, when the interaction brings an
advantage to both partners. ‘‘We were not born pathogens, we be-
come’’ the pathogens would tell us if they could talk . . ., because
they did not decide knowingly to harm us. The mitochondrial
endosymbiosis that is at the origin of the eukaryotic cell is a proof
of that. But, why do some pathogens become dangerous for hu-
mans or, in other words, virulent? This is one of the fundamental
questions of the biology of the 21st century that must be answered
to ensure the public as well as the animal and plant health. Indeed,
health problems do not concern only humans, although they foca-
lise legitimately all our attention.
Without getting caught up in a rigid Neo-Darwinism, it is indis-
putable that in this host/parasite interaction, the «best» ones will
win in a time T and in a space S. Thus, pathogenicity (or virulence)
is just a phenotype – i.e., a product of the genome – a variable that
depends on the genetic organisation of the pathogen and of the
hosts and that, in a given time and space (ecosystem), confers an
advantage to some individuals who survive and reproduce better
than others. Nevertheless, this pathogenicity/virulence has a
downside, because a parasite that eliminates too quickly its host,
as a consequence, will ‘‘commit suicide’’. We will discuss the case
of the H5N1 virus that is the centre of many debates (Gauthier-
Clerc, 2011). This virus is the product of a speciﬁc ecosystem that
has been generated and is maintained by humans: in some region
of Earth where the population density is particularly high, poultry
farms have become true ‘‘biological reactors’’ to which humans add
constantly new raw material (birds, the host). This has allowed the
emergence and the selection of highly pathogenic viral variants the
rapid diffusion of which is favoured by the low genetic diversity of
the farmed animals as they have been selected on criteria of pro-
ductivity. This virulence is thus a phenotypic trait that can be se-
lected and therefore counter-select.
However, surprisingly, the exploitation of pathogen diversity
and of their ecosystem in the combat against their aggressions re-
mains very little developed. Indeed, so far, the majority of the
medicinal compounds (penicillin, artemisin, paracetamol, mor-
phine, quinine and so on, the list would be too long) have come
from the biodiversity of the vegetal world (essentially fungi and
plants) and from the painstaking screening of this diversity by sci-
entists to isolate active principles. Yet, pathogens associate with or
ﬁght against other pathogens within a host – and humans are one
of these hosts – and it has been demonstrated that these associa-
tions of villains can be exploited for our own good. Indeed, co-
infections by multiple pathogens can reduce their virulence (Alizon
and Lion, 2011). This is the case of malaria in Madagascar, where
the presence of intestinal worms (Nematodes) in children seemsto increase their protection against infection by P. falciparum, the
agent of malaria (Brutus et al., 2007). Conversely, herpes virus
infection increases the infection rate of the human immunodeﬁ-
ciency virus (HIV-1), and the cofactor role of sexually transmissible
bacterial infections in HIV transmission is now well established
(Van de Perre et al., 2008). Thus, like all the other wild animals,
parasites ﬁght or help each other. Competition and cooperation,
two laws of ecology and evolution, should be better exploited to
understand and control infectious diseases.
But humans seem to have only one idea in their mind, to which
they consecrate all their energy: the eradication of pathogens.
However, at the risk of shocking, a good pathogen is certainly
not a dead pathogen. If some of them were to disappear, others
would become free to increase their virulence. Otherwise, all
pathogens should be eradicated, which is obviously impossible.
After the end of the Second World War, major medical and techno-
logical advances have nurtured huge hopes concerning the combat
against infections. Wemust admit that, perhaps with the exception
of smallpox, no infectious disease has really disappeared from
Earth, quite the opposite.
In 1988, the international initiative for the global eradication
of poliomyelitis was launched; however, in 2010, although polio-
myelitis is now endemic only in four countries, 23 previously
disease-free states were re-infected due to importation of the
virus. Daily epidemiological reports are in charge of reminding
us about the increasingly worrying progression of resistant
pathogens: resistant Escherichia coli, resistantM. tuberculosis,
resistantS. aureus, resistantP. falciparum and so on. These infec-
tious attacks are scaring and the media do not miss the oppor-
tunity to play scaremongers. However, humans are not
blameless: if virulence and resistance are two phenotypic char-
acteristics of pathogens, it must be acknowledged that far too of-
ten they are favoured by the systematic use of antibiotics
(Hawkey and Jones, 2009) or of other anti-pathogen compounds.
But doctors need to treat the diseased hosts, and thus to use
them. This is a spiral, the happy ending of which is far from
obvious.
Tomorrow’s combat requires other means. We are not any
longer at the stage of the elimination of the infective process –
objective which cannot be attained – but in that of its control
and management. Biological diversity is the natural wealth of
Earth, pathogens are part of this asset, and it is our duty to
understand the ecological and evolutionary modalities of their
interactions with their hosts to get a proﬁt out of them. We
must also understand the interactions between pathogens and
exploit to our advantage the battles they sometimes engage with
other parasites to favour the less virulent ones. This approach
must now be applied globally and not at the individual’s scale,
like in the past. Our mentality must evolve and only the associ-
ation/cooperation of doctors, evolutionary biologists, chemists,
just to mention them, will allow us to progress. In the future
battle against parasites, the phase concerning the treatment of
infected patients is too reductive and comes too late: instead
we must strive to put in place a common, global management
of the risk and of the infectious attack. The future of human
populations depends on this. But we must not forget that the
animal and vegetal worlds are similarly concerned: the emer-
gence of a pathogen which is virulent for rice, for instance, could
indirectly cause as many deaths as the ﬂu due to the risks of
famine. Without an equilibrium built at the planetary scale,
the fall will be inevitable.7. Declaration of interest
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